net dbt
line guidanc cut disappoint
growth guidanc disappoint okay
result came line expect overal solid segment op
off-set higher corpor item includ legal settlement state minnesota
organ growth came estimate compani guidanc low
end posit side price key concern bear
stock y/i estimate strong particularli given apac growth
organ quarter compani ep guidanc cut top end
rang come disappoint organ growth outlook lower high
end well expect drag quarter auto per compani
pre-announce confer watch manag commentari
full year outlook key issu investor overal believ
continu track long term margin improv attract end market exposur
drive sustain long term growth reiter buy rate po
segment op drag corpor legal charg
mmm adj ep came line consensu estim
rel model segment op miss driven higher corpor
drag result compani legal settlement state
minnesota pre-tax charg vs estimate
segment level op healthi tailwind vs model driven
electron stronger margin vs estimate
industri better top line driven fx organ y/i vs estimate
safeti graphic tailwind higher organ top line growth
vs estimate partial off-set health drag lower
margin vs estimate consum headwind lower margin
vs estimate lower tax rate tailwind partial off-set
outlook cut high end lower organ growth
cut ep outlook lower organ
growth outlook vs prior come estimate includ
street high end rang model organ growth
year maintain estim may review model call
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
compani found mine
concern today minnesota-bas compani
diversifi global manufactur busi
technology-driven organ five
segment consum safeti graphic
electron health industri
popular brand includ scotch post-it
thinsul hold us patent
lower cyclic high-return portfolio
view posit investor current
compani well diversifi across end
market geographi
defens less cyclic busi model
focus shorter cycl product stock
defens tend outperform peer
market recess
chart revenu break-out segment
us mn except per share data
corpor unalloc
elimin dual credit
corpor unalloc
elimin dual credit
net incom attribut non-controlling interest
tabl price growth y/i region
tabl organ growth segment geographi
hc healthcar safeti graphic electron
chart industri organ total y/i revenu growth
chart safeti graphic organ total y/i revenu growth
chart electron organ total y/i revenu growth
chart consum organ total y/i revenu growth
chart health organ total y/i revenu growth
chart total organ total y/i revenu growth
po base price-to-earnings line premium consum
good peer trade translat ev/ebitda growth
return characterist histor line high-qual consum
name industri cyclic believ trade
premium multi-industri peer line premium consum good peer
reflect superior growth return
downsid risk po compani larg global emerg market
exposur need greater invest could margin headwind slower-
andrew obin herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
us multi-industrials/engin construct coverag cluster
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
